Genome-wide expression profiling during protection from colitis by regulatory T cells

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Regulatory T cells (Tregs) can prevent colitis development and treat mild cases.
• The precise mechanisms of CD4(+)CD25(+) Treg-mediated immune regulation remain unclear.

Purpose of the Study:

• To identify key immune regulatory pathways by analyzing gene expression profiles.
• To compare gene expression in inflamed colons of mice with colitis versus protected mice.

Main Methods:

• Genome-wide expression profiling using DNA microarrays (Affymetrix GeneChip Mouse Genome 430 2.0 Array).
• Analysis of RNA transcript levels in inflamed and protected mouse rectums.
• Validation of array results with real-time reverse-transcriptase polymerase chain reaction (RT-PCR).

Main Results:

• Colitic samples showed distinct inflammation and growth factor-related transcripts compared to normal mice.
• Treg-protected mice exhibited gene expression profiles similar to normal mice.
• Altered mRNA expression of cytokine, chemokine, and growth factor genes was observed in colitic mice.

Conclusions:

• Specific molecules like STAT3, GATA2, NFkappaB, IL1beta, CXCR3, and CCR1 are implicated in colitis.
• These identified molecules represent potential future therapeutic targets for colitis treatment.